Sera Prognostics, Inc.
NASDAQ:SERAMedical - Diagnostics & Research
-$0.03 today
- Market cap
- $74.11M
- Beta
- 0.94
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.64
Volume 0.01M
Average 0.06M
SERA Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Sera Prognostics, Inc.NASDAQ: SERA
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity falls 28.7% from a year ago
Total equity stood at $67.62M at the end of Q1 FY2026, down 28.7% from a year earlier and down 10.3% from the prior quarter. Over 3 fiscal years it compounded at -8.7% a year.
Context
- Total equity amounted to 72.3% of total assets at the end of Q1 FY2026, down 7.9 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -28.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 75.41M USD
- Year-over-year change
- +57.7%
- 4-year CAGR
- -14.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 75.41M | +57.7% |
| FY2024 | 2024-12-31 | 47.8M | -31.9% |
| FY2023 | 2023-12-31 | 70.16M | -29.1% |
| FY2022 | 2022-12-31 | 98.94M | -28.6% |
| FY2021 | 2021-12-31 | 138.56M | — |
Total Equity vs competitors
How SERA compares with its peers on the latest reported figures
- Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -28.7% is the 6th highest of 9, against a peer median of +79.1%.
- Total equity amounts to 72.3% of total assets for SERA, versus a peer median of 70.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $178.78M USD | +1664.0% | +201.6% | 98.8% | |
| Mar 2026 | $67.62M USD | -28.7% | -8.7% | 72.3% | |
| Mar 2026 | $29.91M USD | +143.8% | -5.2% | 82.8% | |
| Mar 2026 | $23.19M USD | +135.3% | +19.4% | 78.1% | |
| Mar 2026 | $20.4M USD | -68.9% | -41.3% | 32.7% | |
| Mar 2026 | $13.09M USD | +23.0% | -26.8% | 20.8% | |
| Mar 2026 | $4M USD | +174.4% | -22.0% | 11.7% | |
| Mar 2026 | -CA$5.13M CAD | -179.0% | — | 62.9% | |
| Mar 2026 | -$278.15M USD | -5002.1% | — | 230.4% | |
| Peer median (excluding SERA) | — | +79.1% | -13.6% | 70.5% | |
Competitors are the stored peer set for SERA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 58.93M | 29.88M | 3.88M | 4.04M | 3.94M |
| Short-term Investments | 46.18M | 52.83M | 45.2M | 42.19M | 35.26M |
| Net Receivables | 3.14M | 6.11M | 11.47M | 34K | 12K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.99M | 1.31M | 795K | 19K | 1.56M |
| Total Current Assets | 110.25M | 90.13M | 61.34M | 47.6M | 40.77M |
| Property, Plant & Equipment (Net) | 1.77M | 3.06M | 3.18M | 1.85M | 3.55M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 1.03M | 910K |
| Long-term Investments | 34.85M | 21.33M | 30.84M | 21.97M | 56.58M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 157K | 1.82M | 77K | 124K | 123K |
| Total Non-current Assets | 36.78M | 26.2M | 34.1M | 24.98M | 61.16M |
| Total Assets | 147.03M | 116.33M | 95.44M | 72.58M | 101.93M |
| Account Payables | 1.2M | 1.55M | 1.05M | 1.97M | 862K |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 3.12M | 9.08M | 20.24M | 20.22M | 20.32M |
| Other Current Liabilities | 3.56M | 1.07M | 926K | 20.52M | 3.01M |
| Total Current Liabilities | 8.41M | 15.54M | 24.44M | 24.77M | 24.19M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Liabilities | 54K | 1.85M | 840K | 2K | 2.34M |
| Total Liabilities | 8.47M | 17.39M | 25.28M | 24.77M | 26.53M |
| Common Stock | 3K | 3K | 3K | 3K | 4K |
| Retained Earnings | (166.47M) | (210.65M) | (246.9M) | (279.79M) | (311.72M) |
| Accumulated OCI | (183K) | (981K) | (15K) | 60K | 262K |
| Other Stockholders Equity | 0 | 0 | 0 | (0) | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 138.56M | 98.94M | 70.16M | 47.8M | 75.41M |
| Total Debt | 128K | 2.83M | 1.86M | 840K | 2.34M |
| Net Debt | (58.8M) | (27.05M) | (2.02M) | (3.2M) | (1.61M) |
Sera Prognostics, Inc.
NASDAQ:SERA
Intrinsic Alpha fair value
Locked
Current Price
$1.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.